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The search for experimental models mimicking an early stage of Parkinson’s disease
(PD) before motor manifestations is fundamental in order to explore early signs
and get a better prognosis. Interestingly, our previous studies have indicated that
6-hydroxydopamine (6-OHDA) is a suitable model to induce an early degeneration of
the nigrostriatal system without any gross motor impairment. Considering our previous
findings, we aim to implement a novel system to monitor rats after intrastriatal injection of
6-OHDA to detect and analyze physiological changes underlying prodromal PD. Twenty
male Sprague-Dawley rats were unilaterally injected with 6-OHDA (n = 10) or saline
solution (n = 10) into the right striatum and placed in enriched environment cages where
the activity was monitored. After 2 weeks, the amphetamine test was performed before
the sacrifice. Immunohistochemistry was developed for the morphological evaluation
and western blot analysis to assess molecular changes. Home-cage monitoring
revealed behavioral changes in response to 6-OHDA administration including significant
hyperactivity and hypoactivity during the light and dark phase, respectively, turning out
in a change of the circadian timing. A preclinical stage of PD was functionally confirmed
with the amphetamine test. Moreover, the loss of tyrosine hydroxylase expression was
significantly correlated with the motor results, and 6-OHDA induced early proapoptotic
events. Our findings provide evidence for a novel prodromal 6-OHDA model following a
customized monitoring system that could give insights to detect non-motor deficits and
molecular targets to test neuroprotective/neurorestorative agents.
Keywords: 6-hydroxydopamine, circadian rhythms, home-cage monitoring system, prodromal biomarkers,
prodromal Parkinson’s disease symptoms, behavior, non-motor deficits, rat
Abbreviations: ADN, Axodendritic network density; AKT, Protein kinase B; AUC, Area Under the Curve; CL, Contralateral;
EE, Enriched environment; ERK, Extracellular signal-regulated kinase; GFAP, Glial fibrillary acidic protein; IL, Ipsilateral;
NMS, Non-motor symptoms; 6-OHDA, 6-hydroxydopamine; PD, Parkinson’s disease; REM, Rapid eye movement; NREM,
Non-rapid eye movement; RBD, Rapid eye movement sleep behavior disorder; ROC, Receiver Operating Characteristics;
ROS, Reactive oxygen species; SN, substantia nigra; SNr, Substantia nigra reticulate; TH, Tyrosine hydroxylase; TH-ir,
Tyrosine hydroxylase-immunoreactivity; Tpm, Turns per minute; VTA, Ventral tegmental area.
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INTRODUCTION
Parkinson’s disease (PD) is a complex neurologic disorder
in which not only motor impairments occur, but also other
non-motor symptoms (NMS) play a relevant role, including
hyposmia, sleep disorders, depression, constipation and cognitive
deficit (Schapira and Tolosa, 2010; Mantri et al., 2018; Weintraub
et al., 2018). Most of them often appear earlier than the motor
symptomatology, during the so-called prodromal stage and
worsen following the disease’s progression (Schapira et al., 2017).
Indeed, NMS may manifest several years prior to the onset of
motor symptoms, even up to 20 years before the diagnosis, and
the prevalence can vary between the patients (Schapira et al.,
2017; Rees et al., 2019). In this context, although there are not
specific NMS for PD, the presence and combination of various
NMS as well as the correlation with an early dopamine depletion
may be useful for early diagnosis (Berg et al., 2013; Schapira
et al., 2017). Remarkably, slight motor symptoms (<40–60%
of dopaminergic neuronal cell loss) have been also associated
to the prodromal stage when they do not meet the criteria
for the clinical diagnosis of PD (Mahlknecht et al., 2015).
Thus, it is essential to establish a correlation between the early
manifestations of PD (prodromal stage) with the clinical and
pathological stage for an early diagnosis of PD (Mahlknecht et al.,
2015; Liepelt-Scarfone et al., 2017; Sherbaf et al., 2018).
Thus, studies about early events of the disease are emerging
in order to find some biomarker for an early-premotor diagnosis
(Miller and O’Callaghan, 2015). However, the neuroanatomical
and etiological background of NMS in PD remain to be elucidated
(Schapira et al., 2017). One of the first NMS that is suffered by a
high percentage of the patients is the sleep disorder, such as sleep
fragmentation, excessive daytime sleepiness or “REM behavior
disorder” (RBD), which is a pathology based on increasing
muscle tone during the REM (rapid eye movement) sleep (De
Lazzari et al., 2018; De Castro Medeiros et al., 2019). Among the
mechanisms underlying sleep disturbance, the disruption in the
circadian system is attributed as triggering factor (Willison et al.,
2013). Indeed, growing evidences support an association between
circadian disruption and PD, suggesting that the dopamine
depletion may lead to circadian rhythm irregularities including
the alteration of the circadian control of the rest/activity rhythms
(Tanaka et al., 2012; De Lazzari et al., 2018).
In the search for preclinical models of PD, there is a main
challenge for reproducing those functional and pathological
changes that could provide the scaffold to find out about the
target for the design of neuroprotective therapies before the
progression of the disease (Duty and Jenner, 2011; Ko and
Bezard, 2017; Lafuente et al., 2017; Iarkov et al., 2020). In
this context, the well-known model of the 6-hydroxydopamine
(6-OHDA) which is widely used to study motor deficits, can also
be useful for identifying non-motor and early motor impairments
specially when combined with advanced technological devices
(Grandi et al., 2018). In this model, the site of administration
and time elapsed after the injection are critical for determining
the extent and time course of the lesion (Kirik et al., 2000;
Deumens et al., 2002). In our hands, this model is also useful
for studying the preclinical phase of PD, as intrastriatal injection
of 6-OHDA in adult male rats induced an early degeneration of
the nigrostriatal system without any gross motor impairment as
well as upregulation of caspase-3 and downregulation of survival
signaling pathways (Requejo et al., 2018a,b).
Therefore, in the present study we aimed to detect prodromal
changes in the behavior following an experimental model of PD
based on the intrastriatal injection of 6-OHDA with a short time
of evolution (2 weeks) in adult male rats housed in monitored
enriched environment (EE) cages.
MATERIALS AND METHODS
Experimental Design and Housing
Conditions
Twenty adult (3-month-old) male Sprague-Dawley rats,
weighting 280–300 g at the time of surgery, were obtained
from Harlan Laboratories, S, A, (Barcelona, Spain). Rats were
randomly assigned to the following groups: Sham group
(saline-lesioned rats, n = 10) as control and 6-OHDA group
(6-OHDA-lesioned rats, n = 10). After stereotaxic injection
of 6-OHDA or saline solution, the animals were housed for 2
weeks in monitored enriched environment cages (10 animals per
cage) consisting of large cage (790 mm × 460 mm × 640 mm)
with two floors, which were connected by a plastic ramp and
an external running wheel (Figure 1A and Supplementary
Figure S1). A 12 h light/12 h dark cycle was established with
access to food and water ad libitum. The EE cages were developed
by our research group and they were designed to host up to 12
rats as well as housing food feeders, water feeding bottles, two
semi-closed rooms, a wide-open area, and a ramp to access a
runway situated on the upper floor. In addition to this, these
EE cages also provide four gates that may be opened to connect
to other cages, runways, or exercise wheels. Current EE cages
were supplied with an automatic recording system. This novel
system consists, basically, of an infrared camera situated above
every cage and connected to a raspberry device programmed
to collect pictures accurately every 30 s (Figure 1A). In fact, a
Raspberry Pi (Raspberry Pi 2 Model B, Raspberry Pi products,
United Kingdom) is a standalone embedded computer that
measures the size of a credit card. It has enough power to run a
linux operating system and connect it to several external devices
and sensors. In this case, it was connected to Pi NoIR Camera
V2 (Raspberry Pi products, United Kingdom) that provided a
clear image of the cage even at night’s dark due to the infrared
lighting that was set up throughout the room (Supplementary
Figure S1). This in-house customized automatic system
continuously recorded a picture every 30 s and saved it in an
SD Card. At the end of the experiment, more than 60 gigabytes
in pictures were collected and processed in order to measure
changes in the activity (Figure 1B).
Two weeks after the intrastriatal injection the amphetamine
test was performed for evaluating motor deficits and with
the purpose of confirming that no rat presented more than
5 turns per minute (tpm) in order to get a preclinical model
(Supplementary Table S1). This criterium was established
due to the fact that it has previously been shown that
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FIGURE 1 | Experimental design and monitoring analysis. (A) Schematic representation illustrating the timeline of the experiments. Rats received 6-OHDA (6-OHDA
group) or saline solution (Sham group) injections into the right striatum, and immediately after the lesion, they were placed in monitored EE cages for 2 weeks. These
EE cages were supplied with an automatic recording system that collect pictures of the EE cages every 30 s under a regular 12 h:12 h light/dark cycle in order to
detect activity changes during the light and dark phases. Infrared lighting was also set up to take clear pictures during the dark phase. Two weeks later, the
amphetamine test was performed to assess motor symptoms, and then, rats were transcardially perfused or decapitated for the histological and biochemical
analysis, respectively. (B) Data acquisition, pre-processing and analysis workflow. The process was divided in two phases. (1) Image pre-processing (in green): frame
difference, gray level conversion, noise smoothing and binarization). (2) Image analysis (in orange): clustering analysis and centroid calculation, activity analysis.
6-OHDA, 6-hydroxydopamine; EE, enriched environment.
rats rotating more than 5 tpm presented a lesion ranging
from 50 to 90% which may predict motor impairment
(Björklund and Dunnett, 2019). After the amphetamine
test, rats were sacrificed by transcardial perfusion for the
histological evaluation or by decapitation for the biochemical
analysis (Figure 1A).
All the experimental protocols were reviewed and approved
by the Ethical Committee and Animal Welfare of the University
of the Basque Country (UPV/EHU, CEBA M20/2015/024,
approval date 12/28/2015), and in accordance with the
European Community Council Directive on “The Protection
of Animals Used for Scientific Purposes” (2010/63/EU) and
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with Spanish Law (RD 53/2013) for the care and use of
laboratory animals.
6-OHDA Lesions
Rats were lesioned as we previously described (Requejo
et al., 2018a,b). Briefly, thirty minutes before surgery, rats
were pre-treated with desipramine (25 mg/kg, i.p., Sigma,
St. Louis, United States) and pargyline (50 mg/kg, i.p.,
Sigma, St. Louis, United States) in order to preserve the
noradrenergic system and the degradation of the toxin,
respectively. Then, rats were deeply anaesthetized with
isoflurane inhalation (1.5–2%; Esteve Química, Barcelona,
Spain) and placed in the stereotaxic frame (David Kopf R©
Instruments). 6-OHDA (3 µg/µl, in 0.02% ascorbic acid)
or saline solution (0.9% NaCl) was infused using a 10 µl-
Hamilton syringe fitted with a 26-gauge needle at a rate of
0.5 µl/min by a single syringe infusion pump (KDS Scientific,
MA, United States).
To generate a mild lesion of the nigrostriatal pathway, three
injections of 2.5 µl of the 6-OHDA solution (a total volume of
7.5 µl) were administered at three coordinates into the right
striatum, relative to the bregma and dura, with the toothbar
set at −2.4: anteroposterior (AP) + 1.3 mm, mediolateral
(ML) + 2.8 mm, dorsoventral (DV) −4.5 mm; AP −0.2 mm,
ML + 3.0 mm, DV −5.0 mm and AP −0.6 mm, ML + 4.0 mm,
DV −5.5 mm, according to Paxinos and Watson atlas (Paxinos
and Watson, 2013). The needle was left in place for an additional
5 min to allow the toxin to diffuse into the structure, and then
it was slowly retracted. 6-OHDA was prepared daily for each
surgery session and changed every 2–3 h. The 6-OHDA solution
was kept on ice and protected from light during the surgery to
avoid oxidation, which would be indicated by a color change
(clear to brown-pink color). Control rats received the same
volume of saline solution in the same manner. In addition, a short
time of evolution (2 weeks) was elapsed before sacrifice.
Monitoring Analysis
The in-house customized automatic system based on the image
processing with the infrared Camera Module v2 (Pi NoIR;
Raspberry Pi Products, United Kingdom) was used for the
analysis of the rat group behavior. A schematic diagram
of the working procedure for image processing is described
in Figure 1B.
This process was divided in two phases: image pre-processing
and image analysis.
1. In the first phase video sequences were acquired by a high-
quality camera and pre-processed by an own toolbox in
MATLAB to create series of binary image frames of the
rat group activity. The Toolbox includes: (1) function for
image processing, (2) Activity analysis (centroid analysis),
and (3) Period analysis among others. Thus, the activity
areas (motion detection) were calculated based on a frame
difference method (Manchanda and Sharma, 2016; Sengar
and Mukhopadhyay, 2016). Frame absolute difference was
calculated between two consecutive frames with a sampling
period of 30 s. Images were converted from Red Green Blue
(RGB) which is a standard format for color image, into gray
scale, after that in binary images and then by a threshold
filter extracted the main activity area of the system (rats,
and objects moved by the rats). Finally, activity areas were
defined applying morphological filters to reduce the noise
and for smoothing the images. In particular, morphological
filters were applied using MATLAB function bwmorph:
Bwmorph (Ir,’open’);% Remove peaks
Bwmorph (Ir,’close’);% Remove hole
2. During the second phase the trajectories of the animal
group is generated by the system centroid (the average
position of all the activity areas in the binary image)
evolution. The centroid is estimated by k-means algorithm
over the binarized frame series (Eguiraun et al., 2018;
López-de-Ipiña et al., 2019). Thus, within each frame, the
coordinates of the centers of every object were calculated,
and K-means were applied to find the center of the
entire group, that is the “centroid.” A centroid with two
coordinates:
C = (xc, yc)
3. The group trajectory consists of the evolution of that
centroid from the first frame to the last one.
Finally, the rat groups’ behavior was described and modeled
by the following parameters:
1. Number of activity areas in the binary images.
2. Shannon entropy of the centroid trajectory. Shannon
entropy is a main concept in information theory and is
a measure of average uncertainty (information content).
Entropy in biosignals gives information about the system
evolution and behavior and can be applied to analyze
pathological behaviors (Eguiraun et al., 2018; López-de-
Ipiña et al., 2019).
Velocity, speed and acceleration defined as:{
vcx = 1xc/1t
vcy = 1yc/1t (1)
being speed the absolute value of velocity. An acceleration:{
acx = 1vcx/1t
acy = 1vcy/1t (2)
Amphetamine-Induced Rotation Test
Two weeks after intrastriatal injection the amphetamine test
was developed following the previously described methodology
for this behavioral test (Miguelez et al., 2011). Briefly,
D-amphetamine (5 mg/kg in 0.9% NaCl; Sigma-Aldrich,
St. Louis, United States) was intraperitoneally administered
and the animals were placed in an individual circular cage
(rotameter). In the present study, we used a higher dose of
D-amphetamine in order to get rotational behavior due to the
lesion was minor (Björklund and Dunnett, 2019). After 15 min
of latency, the total number of full ipsilateral (IL) rotations
was recorded during 90 min (Multicounter LE3806; Harvad
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Apparatus, Holliston, MA, United States) in order to include the
entire response period and avoid differences in variability due
to the differences in the pharmacokinetics or in the dopamine
release kinetics between rats (Miguelez et al., 2011; Björklund
and Dunnett, 2019). Data were expressed as the number of
turns per minute.
Morphological Analysis
Morphological evaluation was performed as we previously
described (Requejo et al., 2015, 2018a,b).
Tissue Processing for Histological Evaluation
After behavioral test, five rats from each group were
intraperitoneally anesthetized with chloral hydrate at 20%
(Ref: 141,975, Panreac Quimica SA, Barcelona, Spain) and
transcardially perfused with 0.9% sodium chloride followed by
4% paraformaldehyde (PFA) in 0.1 M phosphate-buffered saline
(PBS) pH 7.4. Brains were removed, post-fixed overnight in the
same fixative solution and next transferred into a cryoprotective
solution containing 30% sucrose and 0.1M PBS pH 7.4.50 µm
serial coronal sections containing striatum and substantia nigra
(SN) were obtained with a freezing microtome and collected
following the Paxinos and Watson atlas (Paxinos and Watson,
2013) in 0.6% sodium azide in 0.1 M PBS pH 7.4 for storage and
further analysis.
TH Immunostaining
Tyrosine hydroxylase (TH) immunohistochemical staining was
developed on free-floating coronal slices. Briefly, sections were
treated with 3% H202 and 10% methanol in potassium phosphate
buffered saline (KPBS), preincubated with 5% normal goat serum
(NGS) and 1% Triton X-100 in KPBS (KPBS-T) for 1 h at
room temperature (RT), and later incubated overnight at 4◦C
with rabbit polyclonal anti-TH (Ref: AB-152, Millipore; 1:1,000)
in KPBS/T containing 5% NGS, followed by incubation with
a secondary biotinylated goat anti-rabbit IgG antibody (Ref:
BA1000, Vector Laboratories, Burlingame, CA; 1:200) in 2.5%
NGS KPBS/T for 2 h. Afterward, all sections were processed
with the avidin-biotin-peroxidase complex for 1 h using a
commercial kit (Ref. PK-6102, Elite ABC kit, Vector Laboratories,
Burlingame, CA) and the reaction was shown by using 3,3-
diaminobenzidine (DAB).
Images were visualized, captured and analyzed at 4x and 40x
magnification by an Olympus BX-50 photomicroscope.
Double Immunofluorescence Staining of Caspase-3
and NeuN
Coronal sections were incubated with rabbit anti-caspase
3 (H-277) (Ref: sc-7148, Santa Cruz Biotechnology Inc.,
Spain; 1:50) and monoclonal mouse anti-NeuN (Ref: MAB377,
Chemicon International, Inc., Spain; 1:100) diluted in 5%
bovine serum albumin (BSA) and 0.1% Triton X-100 in
PBS overnight at 4◦C. Sections were subsequently incubated
with secondary antibodies conjugated to Alexa Fluor-488
(Ref: A11029; Invitrogen; 1:400) and Alexa Fluor-568 (Ref:
A11036 Invitrogen; 1:400) for 1 h at room temperature in
darkness. Immunostained sections were further reincubated with
Hoechst for nuclear counterstaining for 10 min, then slices
were washed, mounted on glass slides and coverslipped using
Vectashield mounting medium for fluorescence (Ref: x-0517;
Vector laboratories).
Images were finally analyzed at 20x magnification using
Olympus Fluoview FV500 confocal microscope.
Stereological Analysis
The unbiased stereological analysis was performed as previously
described (Requejo et al., 2015, 2017, 2018a,b) by using a
computerized image analysis system (Mercator Image Analysis
system, Explora Nova, La Rochelle, France) connected to an
Olympus BX-50 photomicroscope. For this purpose, a total of
7–8 sections in a 1: 8 series were analyzed to cover the entire
striatum and SN for each animal.
In brief, in order to evaluate the TH-immunoreactivity (ir)
in the IL striatum, the volume of the preserved striatum was
calculated using the Cavalieri method (Howard and Reed, 2004)
available on Mercator image analysis system by delimiting the
negative areas and the entire striatum at 4x magnification, and
multiplying these measurements by the thickness of the slices
and the intersectional distance (Requejo et al., 2015, 2018a,b).
Values were expressed as the percentage of TH-ir volume of the
IL striatum respect to the total volume of the IL one.
Changes in the density of dopaminergic neurons and
axodendritic network (ADN) were evaluated in both hemispheres
through quantifying the TH-ir neuronal density in the entire SN
and the TH-ir ADN density in the SN reticulata (SNr) using
a stereological tool (an optical fractionator) provided by the
Mercator image analysis system (West et al., 1991). Once the
region of interest was outlined at 4x magnification, probes of
50× 50µm separated by 100µm were launched into the SN. TH-
ir neurons and ADN inside the probe, or crossing the right side of
the X–Y axis, were counted at 40x magnification in the entire SN
and SNr, respectively. Data were expressed as the percentage of
TH-ir neurons or ADN presents on the IL side (lesioned side) vs.
the contralateral (CL) hemisphere (non-lesioned hemisphere).
The study of the topological distribution was performed
following the previously described approach (Requejo et al.,
2015, 2017). For each animal, sections containing the striatum
and the SN were evaluated at three representative rostro-caudal
levels, respectively, according to Paxinos and Watson’s Atlas
(Paxinos and Watson, 2013): rostral (bregma+ 0.70 mm), middle
(bregma, −0.26 mm), and caudal (bregma, −0.80 mm) striatal
sections were considered to determine the TH-ir volume; and
rostral (bregma,−5.20 mm), middle (bregma,−5.60), and caudal
(bregma, −6.04) nigral sections were examined to estimate the
TH-ir neuronal and ADN density.
Biochemical Analysis
Western Blotting
After the behavioral test, 5 rats of each group were anesthetized
with chloral hydrate at 20% (Ref: 141,975, Panreac Quimica
SA, Barcelona, Spain) and decapitated with a rodent
guillotine to obtain fresh brain tissue. IL and CL striatum
and SN were collected by microdissection and quickly frozen
(Chiu et al., 2007). For this purpose, once brains were removed,
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coronal slices containing the striatum and SN were cut out
and subjected to biopsy with a small biopsy needle. Firstly, the
cerebellum was separated, and the brain was cut bi-half into
the right and left hemisphere, next cut was for removing the
olfactory bulb at the level of the optic chiasm, and the fourth cut
was at the level of the pituitary stalk, separating the two coronal
slices, one of them containing the striatum and the other one
the SN. The frontal cortex from the slice containing striatum
was removed in the fifth cut, obtaining the striatum. The SN
was collected in the sixth, separating the cortex from the slice.
Samples were stored at−80◦C until the analysis.
Brain slices were manually homogenized (1:20 w/v) in
lysis buffer [10 mM phosphate-buffered (PB) (pH 7.4), 5 mM
ethylenediaminetetraacetic acid (EDTA), 5 mM ethyleneglycol-
bis(2-aminoethylether)-tetraacetic acid (EGTA), 1 mM
dithiotreitol (DTT)] containing a protease inhibitor cocktail
(Ref: P-8340, Sigma-Aldrich, Spain). Samples were centrifuged
(13,000 rpm at 4◦C for 15 min) and soluble proteins were
recovered in the supernatants and quantified using the Bio-Rad
Protein Assay (Ref: 500-0006, Bio-Rad Laboratories SA, Spain)
based on Bradford’s method (Bradford, 1976).
As previously described (Requejo et al., 2018a,b), for each
sample 20 µg of proteins was loaded into polyacrylamide
CRITERION TGX 12% gels (Bio-Rad Laboratories Inc., Spain)
for electrophoresis and then transferred to a PVDF membrane in
a Trans-Blot Turbo Transfer System (Bio-Rad, United States) for
7 min. Membranes were incubated with the following primary
antibodies: rabbit anti-Phospho-protein kinase B (AKT) (Ser
473) (1:1,000), rabbit anti-AKT (1:1,000), rabbit anti-Phospho-
p44/42 MAPK (extracellular signal-regulated protein kinases 1
and 2 (ERK 1/2)] (Thr202/204) (1:1,000), rabbit anti-P44/42
MAPK (ERK 1/2) (1:1,000) (all of them from Cell Signaling
Technology Inc., United States), rabbit anti-caspase 3 (H-277)
(1:1,000) (Santa Cruz Biotechnology Inc., Spain), rabbit anti-
β-Actin (1:2,000) (Sigma-Aldrich, Spain) and rabbit anti-Beta-
Tubulin (1:1,000) (Novus Biologicals, United States) at 4◦C
overnight. Afterward they were incubated with anti-rabbit IgG
peroxidase conjugated secondary antibodies (1:2,000) (Sigma-
Aldrich, Spain) for 2 h at RT and immunoblots were developed
with an enhanced chemiluminescence kit (GE Healthcare Life
Science, United Kingdom). The luminescence of the reaction
product was detected in a personal scanner, LI-COR C-DiGit (LI-
COR, Bonsai Advanced Technologies SL, Spain), and visualized
bands were analyzed with Image Studio Lite 4.0 software (LI-
COR, Bonsai Advanced Technologies SL, Spain). β-Actin and
β-tubulin were used as loading controls.
Statistical Analysis
All results were expressed as the mean ± SEM (standard
error mean). Statistical analysis was developed with GraphPad
Prism (v 5; GraphPad Software, Inc., United States) and SPSS
Statistics (v 20; IBM Corporation, Armonk, NY, United States).
Prior to the analysis, the Shapiro–Wilk test was used to assess
the normal distribution of the samples, and Levene’s test was
used to determine the homogeneity of variance. Mann-Whitney
U-test was performed to assess differences between groups and
within groups in the monitoring analysis. The ROC (Receiver
Operating Characteristics) curve was performed and the AUC
(Area Under the Curve) was calculated in order to measure
the accuracy of the model which are a metrics for checking
classification models (Hanley and McNeil, 1982; Fawcett, 2006),
in this case: Sham group and 6-OHDA group. The behavioral
data, stereology and densitometry results were analyzed by means
of the two-tailed unpaired Student’s t-test to compare differences
between groups. A one-way analysis of variance (ANOVA)
followed by Tukey’s multiple-comparisons test was used to test
the differences between rostro-caudal gradients within each
experimental group. The correlation was examined by Pearson
product-moment correlation coefficient. Values P < 0.05 were
considered statistically significant.
RESULTS
Behavioral Evaluation
The monitoring of EE cages allows obtaining data about
activity and centroid features (speed, acceleration and entropy)
during the light/dark cycle. Remarkably, 6-OHDA-lesioned rats
decreased significantly the number of activity areas during the
dark phase, which is the active period of the rodent circadian
cycle, comparing to Sham group (∗∗∗p < 0.0001, Mann-Whitney
U-test) (Figure 2B). Moreover, the 6-OHDA group also showed
a significant hyperactivity during the light phase (resting period)
in comparison with control rats which may be related to a
sleep behavior disruption (∗∗∗p< 0.0001, Mann-Whitney U-test;
Figures 2A,B). Overall, these results suggested that animals from
the 6-OHDA group switched their transitional rhythms respect
to the control group. Furthermore, the effect of 6-OHDA on
the disruption of circadian rhythms was also supported by a
significant difference in the activity between both light and dark
phases which was also seen in Sham group (###p< 0.0001 activity
area mean in light cycle vs. activity area mean in dark phase
within the same group, Mann-Whitney U-test; Figure 2B).
In line with these results, although Sham group showed
more remarkable changes between dark and light cycles in
terms of speed and acceleration than 6-OHDA group, entropy
was significantly higher in the 6-OHDA group (6-OHDA
group vs. Sham group, ∗∗∗p < 0.0001, Mann-Whitney U-test;
Figures 2C–E). The fact that entropy was higher supported and
confirmed the incipient sleep pathological condition (Figure 2E).
Both groups also showed significant differences between both
dark and light phases in all the examined parameters related
to the centroid evolution indicating different behaviors in both
phases according to the light or dark period (###p < 0.0001
within the same group, Mann-Whitney U-test; Figures 2C–E).
Besides, the 6-OHDA effect on the acceleration and speed
in both phases pointed to a difficulty in the movement
noticed in both phases.
Thus, this is a model that allows integrating information about
both dark and light phases.
Accordingly, the efficiency of this model was confirmed by the
results obtained by the ROC curve and its AUC which measure
the accuracy of the model by Logistic Regression. In the ROC
curve the true positive rate (Sensitivity) is represented in function
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FIGURE 2 | Circadian rhythm disruption in 6-OHDA-induced rats. (A) Diagram illustrating the motion activity signal in 6-OHDA (upper panel) and Sham (bottom
panel) groups during the whole manuscript. Afterward, the data are preprocessed and selected in order to obtain for the statistical analysis, appropriated balanced
datasets of the light and dark periods for the two groups. Blue: motion activity signal, Green: smoothed signal for control group, Red: smoothed signal for 6-OHDA
group, Yellow: light level. Graphs depict significant activity changes (B), the centroid features including the mean of centroid speed (C), the mean of centroid
acceleration (D) and the entropy mean (E) between 6-OHDA and Sham groups during the light/dark cycle and within the same group. Data are expressed as
mean ± SEM. General analysis was performed by considering 12 h of dark/light periods. Statistical differences appear (p < 0.05) for Mann-Whitney U-test between
both groups and within the same group for both light and dark phases (6-OHDA group vs. Sham group, ***p < 0.001; and light cycle vs. dark cycle within the same
group, ###p < 0.001).
of the false positive rate (1-Specificity) for different operating
points, features of the system, where an AUC of 100% would
represent the highest specificity and sensibility of the model to
separate both groups. Our data gave a ROC curve (each point
on the curve represents a sensitivity/specificity) that reached a
significant AUC of 0.854 giving 85% of sensibility and specificity
to this model (0.854± 0.0047, p = 0; Figure 3).
On the other hand, minimal motor deficits were observed
in the amphetamine test (Supplementary Table S1). Although
animals increased significantly the number of IL turns per minute
(tpm) respect to control group, (1.93± 0.39 tpm vs. 0.32± 0.076
tpm; t(17) = 4.292, p = 0.0005, Unpaired Student’s t-test), no
rats turned more than 3.98 turns per minute (0.79–3.98 tpm;
Supplementary Figure S2).
Therefore, a prodromal stage would be supported by the mild
presence of motor symptoms.
Morphological Evaluation
Once confirmed the functional changes displayed by 6-OHDA
group 2 weeks after 6-OHDA administration, we also assessed
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FIGURE 3 | ROC curve for linear regression. Modeling for 6-OHDA and Sham groups. ROC curve (each point on the curve represents a sensitivity/specificity) that
reached a significant AUC of 0.854 giving 85% of sensibility and specificity to this model (0.854 ± 0.0047, p = 0). ROC, Receiver Operating Characteristics;
6-OHDA, 6-hydroxydopamine; AUC, Area Under the ROC Curve.
whether 6-OHDA exerted a histological effect that we had
previously observed 3 weeks after 6-OHDA administration
(Requejo et al., 2018a,b).
6-OHDA-Induced Mild Nigrostriatal Dopaminergic
Degeneration After a Short Evolution Time
Analysis of TH-immunostained sections from the striatum and
SN confirmed that, at this survival time, 6-OHDA induced
a moderate TH-ir fiber loss either in the striatum or in
the SNr (Figure 4). In addition, dopaminergic neurons
in the SN were not notably reduced (Figures 4E,G).
Rostro-caudal study of TH-ir in the SN indicated that
the number of the survival TH-ir neurons as well as the
TH-ir axodendritic network (ADN) in 6-OHDA group
increased rostro-caudally. Interestingly, one-way ANOVA
followed by Turkey post hoc test indicated significant
differences (*p < 0.05) between rostral and caudal levels
within the 6-OHDA group regarding the number of TH-
ir neurons (35.61 ± 8.89% of TH-ir neuronal cells at the
rostral sections vs. 70.12 ± 7.03% of TH-ir neuronal cells
at the caudal sections; p = 0.031). However, regarding the
number of TH-ir AND no significant differences were
found between rostral and caudal sections [52.24 ± 6.32%
of TH-ir ADN at the rostral sections vs. 76.86 ± 5.29% of
TH-ir of ADN at the caudal section; One-way ANOVA,
F(2, 9) = 3.800, p = 0.063; Figures 4G,H]. In addition to this,
no topological distribution in the TH-ir striatal fibers was
appreciated (Figure 4D).
Correlations Between Motor and Morphological
Changes
The number of IL amphetamine-induced rotations was strongly
correlated with the percentage of TH-ir neuronal cell loss
(r = −0.94) and it was statistically significant (p ≤ 0.05)
(Figure 5B). On the other hand, the TH-ir terminal loss either
in striatum or in SN also showed a correlation with the increase
in the number of IL rotations per minute close to be statistically
significant (r = −0.84, p = 0.073 for TH-ir IL striatal volume and
r =−0.93, p = 0.065 for TH-ir AND; Figures 5A,C).
Biochemical Analysis
In order to assess changes in apoptosis, the expression of caspase-
3 in neuronal cells was morphologically evaluated by double
immunostaining against NeuN (nuclear marker of neuronal cells)
and caspase-3 (apoptosis marker). In addition, caspase-3 levels
were also biochemically analyzed by western blot in the striatum
and SN (Figure 6).
Double immunofluorescence revealed higher caspase-3
immunoreactivity and lower NeuN immunoreactivity in
6-OHDA-lesioned rats compared to Sham group in the IL
striatum as well as in the IL SN. In fact, 6-OHDA induced a
remarkable apoptosis in neuronal cells due to a considerable
amount of NeuN positive cells co-localized with caspase-3 in
6-OHDA group (Figures 6A,C).
Furthermore, immunoblot results were consistent with the
outcomes showed by immunostaining. The expression of
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FIGURE 4 | TH-ir loss in the 6-OHDA-induced preclinical model. (A,B) Rostro-caudal distribution of coronal sections corresponding to the CL and IL striatum and
SN immunostained with tyrosine hydroxylase (TH) in Sham and 6-OHDA groups. (C,D) Graphs show the effects of 6-OHDA on the loss of the TH-ir volume in the IL
striatum comparing to Sham group (***p < 0.001, Unpaired Student’s t-test.) and no significant changes were found along the rostro-caudal axis. (E,F) TH-ir
neuronal density and TH-ir ADN density decrease significantly following 6-OHDA administration comparing to Sham group in the SN (***p < 0.001, Unpaired
Student’s t-test). (G,H) Topological analysis shows a selective vulnerability in the SN to 6-OHDA decreasing the TH-ir neuronal and the TH-ir ADN density
rostro-caudally (*p < 0.05 rostral section vs. caudal section within 6-OHDA group, One-way ANOVA). Data are presented either as the percentage of TH-ir
ipsilateral striatal volume respect to the total ipsilateral one (C,D) or as the percentage of TH-ir neurons (E,G) or TH-ir ADN (F,H) remaining in the IL side respect to
the CL side. Scale bar: 2 mm (A), 1 mm (B). CL, contralateral; IL, ipsilateral; TH-ir, tyrosine hydroxylase immunoreactivity; 6-OHDA, 6-hydroxydopamine; ADN,
axodendritic network; SN, substantia nigra.
FIGURE 5 | Morpho-functional correlation between amphetamine-induced rotations and dopaminergic neurons in SN in addition to dopaminergic terminals in both
striatum and SN after 6-OHDA administration. (A) Amphetamine-induced IL rotations correlate negatively with the % of TH-ir striatal volume IL, (B) also with the % of
TH-ir neuronal density and (C) with the % of TH-ir ADN density. Significance. p < 0.05, IL rotations vs. TH-ir neurons. SN, substantia nigra; 6-OHDA,
6-hydroxydopamine; TH-ir, tyrosine hydroxylase immunoreactivity; IL, ipsilateral.
caspase-3 was upregulated in 6-OHDA-lesioned rats in the
striatum and in SN following a similar pattern (127.9 ± 5.1%
and 127.9± 26.08%, respectively), while caspase-3 activation was
barely evidenced in Sham group (103.8 ± 7.6% in the striatum
and 90.7 ± 7.57% in the SN). However, statistically significant
differences between both groups were only found in the striatum
[t(7) = 2.426, p = 0.045, Unpaired Student’s t-test; Figures 6B,D].
However, no significant changes were seen in the pro-
survival signaling protein levels (AKT and ERK) between
6-OHDA and Sham groups 2 weeks postinjection, despite
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FIGURE 6 | 6-OHDA-induced apoptosis is analyzed by immunofluorescence (A,C) and western blot (B,D) in both striatum and SN. (A) Representative
immunofluorescent images for caspase-3 (red), NeuN (green) and merge images illustrating the ipsilateral striatum from Sham and 6-OHDA groups. Scale
bar = 25 µm. (B) Western blot analysis of caspase-3 levels in the striatum reveals a significant increase in 6-OHDA group comparing to Sham group (*p < 0.05,
Unpaired Student’s t-test). (C) Representative immunofluorescent images for caspase-3 (red), NeuN (green) and merge images illustrating the ipsilateral SN from
Sham and 6-OHDA groups. Scale bar = 25 µm. (D) Western blot analysis of caspase-3 levels in the SN. Actin levels are used as loading control. Densitometric
results are normalized with actin and they are set as the % of the caspase-3/actin ratio in the ipsilateral hemisphere respect to the contralateral one. 6-OHDA,
6-hydroxydopamine; SN, substantia nigra.
both proteins were downregulated in the 6-OHDA group
(Supplementary Figure S3).
DISCUSSION
In the present study, we achieved to monitor the alteration of
the circadian cycle in a preclinical model with an automatized
and non-invasive method. Indeed, our results evidenced
that 2 weeks after the administration of 6-OHDA in the
striatum of adult male rats despite inducing only a subclinical
motor deficit, other physiological impairments associated
with the premotor phase of PD were found. These were
related to mild morphological and molecular changes in the
dopaminergic system.
Remarkably, our results suggested that 6-OHDA-lesioned
rats showed sleep behavioral disruption as an effect of
dysfunctional circadian clock. Circadian disruption consists
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in the alteration at the level of the daily rest/activity rhythm
(De Lazzari et al., 2018) and involves to multiple systems,
thereby some authors speculate that circadian disfunction
can worsen the progression of PD (Willison et al., 2013;
Fifel, 2017; De Castro Medeiros et al., 2019). Thus, the
use of PD models that reproduce sleep and circadian
abnormalities as well as the design of systems that aid to
collect data about the evolution of the activity changes in
circadian rhythms as we described in this study represent a
good strategy for predicting PD prior to the clinical motor
deficits manifestation.
In particular, our findings indicated that 6-OHDA-lesioned
rats switched their circadian rhythms respect to the control
animals reflecting alterations in the temporal patterning of
sleep as was previously described in PD patients (Willison
et al., 2013). Thus, we can speculate that this change in the
pattern of rest/activity seen in response to 6-OHDA may be
similar to the insomnia at night or the hypersomnia during
the daytime experimented by PD patients (De Castro Medeiros
et al., 2019). Behavioral changes related to circadian cycles were
already described in the 6-OHDA model, such as alterations on
circadian locomotor rhythm parameters (Ben and Bruguerolle,
2000; Gravotta et al., 2011; Masini et al., 2017; De Lazzari
et al., 2018; Souza et al., 2018; Ciric et al., 2019; De Castro
Medeiros et al., 2019). In fact, some of these studies associated
the circadian disruption with the loss of dopaminergic neurons
indicating that dopamine may act as a modulator of the
circadian system (Isobe and Nishino, 2001; Gravotta et al.,
2011; De Lazzari et al., 2018; Souza et al., 2018; Ciric et al.,
2019; De Castro Medeiros et al., 2019). Interestingly, our
findings are in agreement with these studies, however, we
detect changes in both light and dark phases on a regular
12:12 light-dark cycle during 2 weeks after unilateral striatal 6-
OHDA lesion. Thus, we also suggest that the early alteration
on the circadian rhythms may help to predict the dopamine
depletion. In line with our results, Sakata and collaborators
found alterations in the sleep behavior in both, light and dark
phases. They reported after bilateral injection of 6-OHDA into
the ventral tegmental area (VTA) a decrease in REM sleep
during the light phase contrary to the dark phase, in which
they observed an increase in REM sleep and in non-rapid eye
movement (NREM) as well as a reduction in spontaneous activity
(Sakata et al., 2002).
The tendency to decrease the activity during the dark
phase in response to 6-OHDA was also in accordance
with other studies, some of them suggested that 6-OHDA-
lesioned rats may show slightly motor impairment and
more diurnal activity during the first week after 6-OHDA
administration into the SN (Souza et al., 2018). While other
studies did not detect activity change during the light phase
(Masini et al., 2017).
In addition, 6-OHDA-induced activity changes were
also supported by the reduction of speed and acceleration
during the light/dark cycle even in the light phase where
6-OHDA-lesioned rats were more active than control rats.
These findings may indicate that 6-OHDA-lesioned animals
started to present difficulty in the movement. Thus, the
assumption of the scarcely motor symptoms as a consequence
of circadian disruption reinforces our hypothesis about 6-
OHDA enables to induce mild motor symptoms in this model
and although they are almost undetectable by conditional
motor test. Early motor impairment might be detected
by a sophisticated continuous monitoring system like the
system we propose.
On the other hand, due to Shannon entropy is often
considered as one of the classic and most natural way to
measure the expected value (average) of the information
in a dysfunctional signal (Eguiraun et al., 2018; López-
de-Ipiña et al., 2019), the increase of entropy exhibited
by 6-OHDA-lesioned rats confirmed the incipient sleep
behavioral disorder.
Moreover, the reliability of this model was also confirmed
by the high sensibility and specificity that we found allowing
us the correct screening of both animal groups. Taken
altogether, we propose the sleep disruption as a promising
biomarker to be addressed using the 6-OHDA model in the
reported conditions.
Concerning the motor evaluation developed with
amphetamine test, the mild increased number of IL rotations
was related to a mild degree of denervation in the dorsal
subregion of the striatum and with the subsequent mild loss
of dopaminergic terminals and neuronal cells in the SN.
Interestingly, this correlation pointed out to the accurately or
sensitivity of the amphetamine test predicting the dopamine
decline (Decressac et al., 2012). Moreover, the mild motor
deficit displayed by 6-OHDA-lesioned rats may result in the
circadian locomotor activity reduction previously reported in
the monitoring analysis. On the other hand, motor evaluation
of 6-OHDA lesion was only carried out with the amphetamine
test due to the apomorphine test, which is based on the
subcutaneous administration of apomorphine to test CL
rotations, only predicts an extensive lesion (nearly complete
dopamine depletion) (Hudson et al., 1993; Dziewczapolski
et al., 1996; Deumens et al., 2002; Yuan et al., 2005; Bilbao
et al., 2006). In contrast, the amphetamine test detects motor
impairments with only 50% neuronal loss allowing us to assess
more moderate lesions (Bilbao et al., 2006). Therefore, the
amphetamine test is commonly used in the 6-0HDA model to
monitor motor changes and predict the degree of the lesion
(Björklund and Dunnett, 2019).
The loss of dopaminergic neurons or fibers found in this
model was around 45–55%, indicating that the degree of lesion
was lower than the results reported 3 weeks after lesion (Requejo
et al., 2018a,b). Thus, the dopamine depletion did not reach
the required threshold to develop motor symptoms (Deumens
et al., 2002; Padmanabhan and Burke, 2018). However, this loss
of dopamine could be sufficient to induce disruption of the
circadian rhythms contrary to other studies which suggested
a higher dopaminergic neuronal loss (about 60%) in order to
detect disruption of circadian locomotor (Souza et al., 2018).
In addition, results indicated that a selective vulnerability to
the toxin could be observed, pointing out to a dopamine
decline topologically distributed in the SN, in concordance
with our previous works (Requejo et al., 2015, 2017). In
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fact, most of the dopaminergic neurons and dopaminergic
terminals remained in the caudal axis, decreasing the survival
toward rostral axis.
Regarding the mechanisms may underlay the early
6-OHDA-induced neurodegenerative effect on the dopaminergic
system; we tested the effect of this toxin over apoptotic
cascade and the survival signaling pathways in the striatum
and SN. The toxicity mediated by 6-OHDA was able to
activate the proapoptotic pathway in neurons increasing
caspase-3 levels in the striatum and SN. Indeed, the most
remarkable outcomes were found in the striatum where the
toxin was injected. These findings supported the capacity of
6-OHDA to trigger the activation of caspase-3 for inducing
the cell death through the production of ROS leading to the
apoptosis in agreement with other studies (Hernandez-Baltazar
et al., 2013). Thus, the early reduction of ROS production
could be a strategy to avoid proapoptotic events and the
subsequent cell death.
Protein kinase B (AKT) signaling pathway as well as
extracellular signal-regulated kinase (ERK) activation play a
pivotal role in the regulation of cellular survival and in
the inhibition of cell death (Smith and Dahodwala, 2014).
However, the effect of 6-OHDA 2 weeks after administration
was not sufficient to induce remarkable changes either in
AKT or ERK expression in the nigrostriatal pathway. However,
our previous studies have shown that the activation of both
survival pathways were reduced significantly 3 weeks after
6-OHDA administration (Requejo et al., 2018b). Thereby,
although proapoptotic events were evident 2 weeks after lesion,
additional time will be required in order to detect changes in
survival pathways.
Finally, for the present study the use of EE cages was only with
the purpose of monitoring the behavior and assessing functional
parameters. In fact, we propose a novel tracking system that
allows monitoring animals in their home cages automatically
detecting and categorizing behaviors without conditioning their
regular environment. Interestingly, our observations indicated
that monitored EE cages provided novel additional information
for screening changes in the circadian function by monitoring
parameters of circadian locomotor activity rhythms (activity area,
speed and acceleration, among others) automatically during the
light/dark cycle. Since there are discrepancies concerning to
the parameters and methods for the evaluation of the active
state of the animals (De Castro Medeiros et al., 2019), this
monitoring system may represent a promising strategy offering a
plethora of different activity parameters to assess along with other
additional information about the state of the animal during the
light/dark cycle.
CONCLUSION
In conclusion, we provide evidences about the suitability of
the 6-OHDA-induced model reproducing the prodromal sleep
disruption and we implemented a novel system to monitor
behavior changes providing an optimal system to test different
neuroprotective/neuroregenerative strategies.
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